Out of hospital management of LVAD patients during COVID‐19 outbreak

Abstract

Coronavirus disease 2019 (COVID-19) is a pandemic touching thousands of people all around the world. Patients supported with left ventricular assist devices (LVADs) are affected by long-standing cardiovascular diseases and subjected to variations of the normal cardiovascular physiology, thus requiring an even closer monitoring dur-How to cite this article:

Telemedicine in Heart Failure During COVID-19: A Step Into the Future

“…Furthermore, heart transplant recipients on stable immunosuppression at low risk for allograft rejection and hemodynamically optimized LVAD patients may be managed remotely without exposing them to further unnecessary risks ( 9 ). A telemonitoring algorithm for patients with LVAD has been recently proposed ( 38 ), and it is potentially adaptable to every LVAD center, regardless of the number of LVAD patients or previous experiences.…”

Cardiovascular-related health behaviors and lifestyle during the COVID-19 pandemic: An infodemiology study

“…patients diagnosed with breast cancer for whom a risk-stratified prioritization algorithm has recently been put forward [ 35 ]. While there is ample evidence emerging on the care of CVD patients during the pandemic [ [36] , [37] ], the effective use of healthcare resources in post-pandemic times with months-long delays in diagnostic and therapeutic procedures currently remains an unsolved problem that needs urgent attention.…”

Commentary: From the trenches: Lessons on caring for patients with heart failure during coronavirus disease 2019 (COVID-19)

“…This expert opinion adds to the growing literature on how to best manage patients with heart failure during COVID-19. [2][3][4][5][6] Although not an official guideline document, this coalescence of best practices from expert heart failure caregivers on the front lines of COVID-19 care will prove useful as a reference document on operationalizing crisis management for other LVAD and transplant programs. In fact, it is difficult, if not impossible, at this stage to provide formal guidelines for the management of patients with heart failure during the COVID-19 pandemic.…”